The global Addictions Therapeutics market is projected to grow from US$ 4975.1 million in 2024 to US$ 6401.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.

Addictions Therapeutics Market

Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.

Market Analysis and Insights: Global Addictions Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Addictions Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Addictions Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Addictions Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Addictions Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Addictions Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Addictions Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Addictions Therapeutics Market Report

Report Metric	Details
Report Name	Addictions Therapeutics Market
Accounted market size in 2024	US$ 4975.1 million
Forecasted market size in 2030	US$ 6401.2 million
CAGR	4.3
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Alcohol Addiction Therapeutics Tobacco Addiction Therapeutics Drug Addiction Therapeutics
Segment by Application	Public Private Government
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Opiant Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Addictions Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Addictions Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Addictions Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Addictions Therapeutics Market growing?

Ans: The Addictions Therapeutics Market witnessing a CAGR of 4.3 during the forecast period 2025-2030.

What is the Addictions Therapeutics Market size in 2030?

Ans: The Addictions Therapeutics Market size in 2030 will be US$ 6401.2 million.

Who are the main players in the Addictions Therapeutics Market report?

Ans: The main players in the Addictions Therapeutics Market are Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Opiant Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Addictions Therapeutics Market report?

Ans: The Applications covered in the Addictions Therapeutics Market report are Public, Private, Government

What are the Type segmentation covered in the Addictions Therapeutics Market report?

Ans: The Types covered in the Addictions Therapeutics Market report are Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, Drug Addiction Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Addictions Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Alcohol Addiction Therapeutics

1.2.3 Tobacco Addiction Therapeutics

1.2.4 Drug Addiction Therapeutics

1.3 Market by Application

1.3.1 Global Addictions Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Public

1.3.3 Private

1.3.4 Government

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Addictions Therapeutics Market Perspective (2019-2030)

2.2 Global Addictions Therapeutics Growth Trends by Region

2.2.1 Addictions Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Addictions Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Addictions Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Addictions Therapeutics Market Dynamics

2.3.1 Addictions Therapeutics Industry Trends

2.3.2 Addictions Therapeutics Market Drivers

2.3.3 Addictions Therapeutics Market Challenges

2.3.4 Addictions Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Addictions Therapeutics by Players

3.1.1 Global Addictions Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Addictions Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Addictions Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Addictions Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Addictions Therapeutics Market Concentration Ratio

3.4.1 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Addictions Therapeutics Revenue in 2023

3.5 Global Key Players of Addictions Therapeutics Head office and Area Served

3.6 Global Key Players of Addictions Therapeutics, Product and Application

3.7 Global Key Players of Addictions Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Addictions Therapeutics Breakdown Data by Type

4.1 Global Addictions Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Addictions Therapeutics Forecasted Market Size by Type (2025-2030)

5 Addictions Therapeutics Breakdown Data by Application

5.1 Global Addictions Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Addictions Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Addictions Therapeutics Market Size (2019-2030)

6.2 North America Addictions Therapeutics Market Size by Type

6.2.1 North America Addictions Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Addictions Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Addictions Therapeutics Market Share by Type (2019-2030)

6.3 North America Addictions Therapeutics Market Size by Application

6.3.1 North America Addictions Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Addictions Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Addictions Therapeutics Market Share by Application (2019-2030)

6.4 North America Addictions Therapeutics Market Size by Country

6.4.1 North America Addictions Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Addictions Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Addictions Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Addictions Therapeutics Market Size (2019-2030)

7.2 Europe Addictions Therapeutics Market Size by Type

7.2.1 Europe Addictions Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Addictions Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Addictions Therapeutics Market Share by Type (2019-2030)

7.3 Europe Addictions Therapeutics Market Size by Application

7.3.1 Europe Addictions Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Addictions Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Addictions Therapeutics Market Share by Application (2019-2030)

7.4 Europe Addictions Therapeutics Market Size by Country

7.4.1 Europe Addictions Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Addictions Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Addictions Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Addictions Therapeutics Market Size (2019-2030)

8.2 China Addictions Therapeutics Market Size by Type

8.2.1 China Addictions Therapeutics Market Size by Type (2019-2024)

8.2.2 China Addictions Therapeutics Market Size by Type (2025-2030)

8.2.3 China Addictions Therapeutics Market Share by Type (2019-2030)

8.3 China Addictions Therapeutics Market Size by Application

8.3.1 China Addictions Therapeutics Market Size by Application (2019-2024)

8.3.2 China Addictions Therapeutics Market Size by Application (2025-2030)

8.3.3 China Addictions Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Addictions Therapeutics Market Size (2019-2030)

9.2 Asia Addictions Therapeutics Market Size by Type

9.2.1 Asia Addictions Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Addictions Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Addictions Therapeutics Market Share by Type (2019-2030)

9.3 Asia Addictions Therapeutics Market Size by Application

9.3.1 Asia Addictions Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Addictions Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Addictions Therapeutics Market Share by Application (2019-2030)

9.4 Asia Addictions Therapeutics Market Size by Region

9.4.1 Asia Addictions Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Addictions Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Addictions Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Addictions Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Addictions Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Addictions Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Alkermes Plc

11.1.1 Alkermes Plc Company Details

11.1.2 Alkermes Plc Business Overview

11.1.3 Alkermes Plc Addictions Therapeutics Introduction

11.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2019-2024)

11.1.5 Alkermes Plc Recent Developments

11.2 Amneal Pharmaceuticals Inc.

11.2.1 Amneal Pharmaceuticals Inc. Company Details

11.2.2 Amneal Pharmaceuticals Inc. Business Overview

11.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Introduction

11.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2019-2024)

11.2.5 Amneal Pharmaceuticals Inc. Recent Developments

11.3 Indivior Plc

11.3.1 Indivior Plc Company Details

11.3.2 Indivior Plc Business Overview

11.3.3 Indivior Plc Addictions Therapeutics Introduction

11.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2019-2024)

11.3.5 Indivior Plc Recent Developments

11.4 Johnson & Johnson Services Inc.

11.4.1 Johnson & Johnson Services Inc. Company Details

11.4.2 Johnson & Johnson Services Inc. Business Overview

11.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Introduction

11.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2019-2024)

11.4.5 Johnson & Johnson Services Inc. Recent Developments

11.5 Mylan NV

11.5.1 Mylan NV Company Details

11.5.2 Mylan NV Business Overview

11.5.3 Mylan NV Addictions Therapeutics Introduction

11.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2019-2024)

11.5.5 Mylan NV Recent Developments

11.6 Novartis AG

11.6.1 Novartis AG Company Details

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Addictions Therapeutics Introduction

11.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2019-2024)

11.6.5 Novartis AG Recent Developments

11.7 Novo Nordisk AS

11.7.1 Novo Nordisk AS Company Details

11.7.2 Novo Nordisk AS Business Overview

11.7.3 Novo Nordisk AS Addictions Therapeutics Introduction

11.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2019-2024)

11.7.5 Novo Nordisk AS Recent Developments

11.8 Opiant Pharmaceuticals Inc.

11.8.1 Opiant Pharmaceuticals Inc. Company Details

11.8.2 Opiant Pharmaceuticals Inc. Business Overview

11.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Introduction

11.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2019-2024)

11.8.5 Opiant Pharmaceuticals Inc. Recent Developments

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Details

11.9.2 Pfizer Inc. Business Overview

11.9.3 Pfizer Inc. Addictions Therapeutics Introduction

11.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2019-2024)

11.9.5 Pfizer Inc. Recent Developments

11.10 Teva Pharmaceutical Industries Ltd.

11.10.1 Teva Pharmaceutical Industries Ltd. Company Details

11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Introduction

11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2019-2024)

11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Alkermes plc

Amneal Pharmaceuticals, Inc.

Johnson & Johnson Services Inc.

Mylan NV

Novartis

Novo Nordisk AS

Opiant Pharmaceuticals Inc

Pfizer Inc

Teva Pharmaceutical Industries Ltd

List of Tables

Table 1. Global Addictions Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Alcohol Addiction Therapeutics

Table 3. Key Players of Tobacco Addiction Therapeutics

Table 4. Key Players of Drug Addiction Therapeutics

Table 5. Global Addictions Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Addictions Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Addictions Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Addictions Therapeutics Market Share by Region (2019-2024)

Table 9. Global Addictions Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Addictions Therapeutics Market Share by Region (2025-2030)

Table 11. Addictions Therapeutics Market Trends

Table 12. Addictions Therapeutics Market Drivers

Table 13. Addictions Therapeutics Market Challenges

Table 14. Addictions Therapeutics Market Restraints

Table 15. Global Addictions Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Addictions Therapeutics Revenue Share by Players (2019-2024)

Table 17. Global Top Addictions Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Addictions Therapeutics as of 2023)

Table 18. Global Addictions Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Addictions Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Addictions Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Addictions Therapeutics, Product and Application

Table 22. Global Key Players of Addictions Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Addictions Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Addictions Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Addictions Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Addictions Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Addictions Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Addictions Therapeutics Revenue Share by Application (2019-2024)

Table 30. Global Addictions Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Addictions Therapeutics Revenue Share by Application (2025-2030)

Table 32. North America Addictions Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Addictions Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Addictions Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Addictions Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Addictions Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Addictions Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Addictions Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Addictions Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Addictions Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Addictions Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Addictions Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Addictions Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Addictions Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Addictions Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Addictions Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Addictions Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Addictions Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Addictions Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Addictions Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Addictions Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Addictions Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Addictions Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Addictions Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Addictions Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Addictions Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Addictions Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Addictions Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 64. Alkermes Plc Company Details

Table 65. Alkermes Plc Business Overview

Table 66. Alkermes Plc Addictions Therapeutics Product

Table 67. Alkermes Plc Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Alkermes Plc Recent Developments

Table 69. Amneal Pharmaceuticals Inc. Company Details

Table 70. Amneal Pharmaceuticals Inc. Business Overview

Table 71. Amneal Pharmaceuticals Inc. Addictions Therapeutics Product

Table 72. Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 73. Amneal Pharmaceuticals Inc. Recent Developments

Table 74. Indivior Plc Company Details

Table 75. Indivior Plc Business Overview

Table 76. Indivior Plc Addictions Therapeutics Product

Table 77. Indivior Plc Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Indivior Plc Recent Developments

Table 79. Johnson & Johnson Services Inc. Company Details

Table 80. Johnson & Johnson Services Inc. Business Overview

Table 81. Johnson & Johnson Services Inc. Addictions Therapeutics Product

Table 82. Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 83. Johnson & Johnson Services Inc. Recent Developments

Table 84. Mylan NV Company Details

Table 85. Mylan NV Business Overview

Table 86. Mylan NV Addictions Therapeutics Product

Table 87. Mylan NV Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 88. Mylan NV Recent Developments

Table 89. Novartis AG Company Details

Table 90. Novartis AG Business Overview

Table 91. Novartis AG Addictions Therapeutics Product

Table 92. Novartis AG Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Novartis AG Recent Developments

Table 94. Novo Nordisk AS Company Details

Table 95. Novo Nordisk AS Business Overview

Table 96. Novo Nordisk AS Addictions Therapeutics Product

Table 97. Novo Nordisk AS Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Novo Nordisk AS Recent Developments

Table 99. Opiant Pharmaceuticals Inc. Company Details

Table 100. Opiant Pharmaceuticals Inc. Business Overview

Table 101. Opiant Pharmaceuticals Inc. Addictions Therapeutics Product

Table 102. Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Opiant Pharmaceuticals Inc. Recent Developments

Table 104. Pfizer Inc. Company Details

Table 105. Pfizer Inc. Business Overview

Table 106. Pfizer Inc. Addictions Therapeutics Product

Table 107. Pfizer Inc. Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Pfizer Inc. Recent Developments

Table 109. Teva Pharmaceutical Industries Ltd. Company Details

Table 110. Teva Pharmaceutical Industries Ltd. Business Overview

Table 111. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product

Table 112. Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2019-2024) & (US$ Million)

Table 113. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Addictions Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Addictions Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Alcohol Addiction Therapeutics Features

Figure 4. Tobacco Addiction Therapeutics Features

Figure 5. Drug Addiction Therapeutics Features

Figure 6. Global Addictions Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Addictions Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Public Case Studies

Figure 9. Private Case Studies

Figure 10. Government Case Studies

Figure 11. Addictions Therapeutics Report Years Considered

Figure 12. Global Addictions Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Addictions Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Addictions Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Addictions Therapeutics Market Share by Players in 2023

Figure 16. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Addictions Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Addictions Therapeutics Revenue in 2023

Figure 18. North America Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Addictions Therapeutics Market Share by Type (2019-2030)

Figure 20. North America Addictions Therapeutics Market Share by Application (2019-2030)

Figure 21. North America Addictions Therapeutics Market Share by Country (2019-2030)

Figure 22. United States Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Addictions Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Addictions Therapeutics Market Share by Type (2019-2030)

Figure 26. Europe Addictions Therapeutics Market Share by Application (2019-2030)

Figure 27. Europe Addictions Therapeutics Market Share by Country (2019-2030)

Figure 28. Germany Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Addictions Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Addictions Therapeutics Market Share by Type (2019-2030)

Figure 36. China Addictions Therapeutics Market Share by Application (2019-2030)

Figure 37. Asia Addictions Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Addictions Therapeutics Market Share by Type (2019-2030)

Figure 39. Asia Addictions Therapeutics Market Share by Application (2019-2030)

Figure 40. Asia Addictions Therapeutics Market Share by Region (2019-2030)

Figure 41. Japan Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Addictions Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Addictions Therapeutics Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Addictions Therapeutics Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Addictions Therapeutics Market Share by Country (2019-2030)

Figure 51. Brazil Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Addictions Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Alkermes Plc Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 58. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 59. Indivior Plc Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 60. Johnson & Johnson Services Inc. Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 61. Mylan NV Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 62. Novartis AG Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 63. Novo Nordisk AS Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 64. Opiant Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 65. Pfizer Inc. Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 66. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Addictions Therapeutics Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions